Most Popular Articles

Here is the content currently trending at Cantech Letter…

1. After selling Paladin Labs, Jonathan Goodman hasn’t taken his foot off the pedal. He has now invested over $60 million in his latest venture, Knight Therapeutics.

Investors follow Paladin’s Goodman to Knight Therapeutics

2. While most Canadian tech stocks are doing better than they have in years, it isn’t a clean sweep. We count down some of the laggards. We rank the TSX Venture Exchange stocks that have stalled out of the gate in 2014. These companies are ranked according to how closely they are trading to their 52-weeek low.

Ten TSX Venture Tech Stocks Trading at or Near 52 Week Lows

3. U.S. biotech stocks partied like it was 1999 last year, posting their biggest gains since then. But Canada’s Life Sciences sector performed even better. Can they keep it up in 2014? These tens stocks are certainly doing their part.

Canadian Biotech Stocks: The Ten Best Performers So Far in 2014

4. You’ve without doubt heard about the $5.23 billion, 12-year deal that Rogers Communications signed with the NHL back in November, through which TSN and the CBC have basically been shut out of the NHL’s broadcast future in Canada. But did you know that Rogers is picking up a persistent money loser in the legendary property?

Roger That? How “Hockey Night In Canada” Ended Up Losing the CBC Money